Affordable Insulin for the COVID–19 Emergency Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (May 28, 2020)
Affordable Insulin for the COVID-19 Emergency Act
This bill eliminates cost-sharing under the Medicare prescription drug benefit and Medicare Advantage for insulin and associated medical supplies during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019). The bill also allows beneficiaries to receive their insulin and supplies via mail order during the emergency period.
What just happenedMay 28, 2020
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Who’s behind it
- Introduced in HouseMay 28, 2020
- May 28, 2020IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - May 28, 2020IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - May 28, 2020IntroReferralIntro-H
Introduced in House
- May 28, 2020IntroReferral1000
Introduced in House